Inhibition of serotonin-induced platelet aggregation in relation to thrombus production.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000818:Animals; D001532:Atropa belladonna / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003720:Densitometry; D004155:Diphenhydramine / Q000494:pharmacology; D005337:Fibrin / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008722:Methods; D010946:Plants, Medicinal; D010947:Plants, Toxic; D010949:Plasma; D012702:Serotonin Antagonists; D012756:Sheep; D013917:Thrombin / Q000494:pharmacology; D013927:Thrombosis / Q000209:etiology
D000227:Adenine Nucleotides; D012702:Serotonin Antagonists; D001285:Atropine; D004155:Diphenhydramine; D008238:Lysergic Acid Diethylamide; D005337:Fibrin; D013917:Thrombin; D007099:Imipramine; D002746:Chlorpromazine